INTRODUCTION
Disturbances in the balance between oxygenderived free radicals and antioxidant defences may contribute to the pathogenesis of certain diseases of the preterm infant such as chronic lung disease retinopathy of prematurity [2, 31 and intraventricular haemorrhage (IVH) [3] . Preterm infants are deficient in some antioxidants and are under increased oxidant stress. There is the potential for therapeutically augmenting antioxidants whose deficiency contributes to human diseases.
Antioxidant defences include antioxidant enzymes (such as superoxide dismutase, catalase, glutathione peroxidase) and the metal binding proteins, which prevent the formation of free radicals. A second line of defence is provided by antioxidants which scavenge free radicals, converting them into less toxic species, e.g. vitamin C, vitamin E, p-carotene, bilirubin, uric acid and glutathione. Preterm infants have been shown to be deficient in plasma antioxidants including vitamin E, p-carotene and caeruloplasmin and have low levels of transferrin, which can result in higher circulating non-proteinbound iron [9] , which facilitates the formation of the damaging hydroxyl radical. Bilirubin has been shown to be a physiologically important chain-breaking antioxidant, interrupting the chain reaction of lipid peroxidation in v i m [lo, 111, although studies in humans have shown conflicting results with regard to a protective effect in retinopathy of prematurity [12-151 and chronic lung disease [16] . A meta-analysis of studies of vitamin E prophylaxis showed that supplementation did not prevent chronic lung disease [17] . However, it did have a beneficial effect on the prevention of IVH [18, 191 . Two randomized placebo-controlled studies of vitamin A prophylaxis have shown a beneficial effect of supplementation in reducing chronic lung disease [20, 211. Elevated malondialdehyde (MDA) has previously been reported in the plasma [22] and urine [23] of preterm infants with adverse outcome. Using the total antioxidant status (TAS) assay, the antioxidant status of preterm babies has been shown, in one study, to be depressed when compared with term babies [6] .
The aim of this study was to investigate whether increased free radical activity as evidenced by the lipid peroxidation end-product MDA was related to depressed antioxidant status (as measured by TAS), and to determine whether plasma antioxidant status using this method was related to complications of prematurity.
MATERIALS AND METHODS

Patients
The Local Research Ethics Committee approved the study, and parental assent was obtained.
Antioxidant status and lipid peroxidation. In fan ts admitted to the Neonatal Intensive Care Unit at Liverpool Women's Hospital between March and August 1995 were included in the study to investigate the relationship between plasma antioxidant status and oxygen-derived free-radical-induced lipid peroxidation. Blood samples were taken at various times during the first 11 days of life at the same time as routine clinical samples. Plasma was stored under argon at -30°C until analysis for MDA and TAS.
Antioxidant status and outcome. Infants of less than 34 weeks gestation born during November 1995 and January 1996 at Liverpool Women's Hospital and admitted to the Neonatal Unit were included in the study to determine whether plasma antioxidant status was related to complications of prematurity. Blood samples were taken at the same time as routine clinical samples within 12 h of birth, and on days 4 and 10, into lithium heparin tubes, and centrifuged to separate the plasma which was subsequently stored at -30°C until analysis for TAS, plasma bilirubin, urate and albumin levels. Demographic and neonatal treatment variables were documented prospectively. Cranial ultrasound scans were routinely made in the first 24 h of birth and subsequently at regular intervals until discharge. Regular screening for retinopathy was undertaken by one paediatric ophthalmologist. Outcome measures were oxygen dependency at 28 days and at 36 weeks postconceptional age, grade of IVH, stage of retinopathy and mortality.
MDA measurement
MDA is still the mostly widely used index of lipid peroxidation despite numerous limitations. It is formed during Fe2+-catalysed decomposition of hydroxy-endoperoxides and can be cheaply and easily assayed by the thiobarbituric acid (TBA) reaction. The introduction of an antioxidant such as butylated hydroxytoluene to prevent decomposition of lipid hydroperoxides to MDA during the assay, coupled with chromatographic separation by HPLC, has improved the specificity of the assay. The method has been described previously [24] . Briefly, a Kontron 420 HPLC pump, Waters Lambda Max UV detector set at 532nm, Hewlett Packard 3392A integrator, Waters pBondapak C18, 10 pm 3.9x300mm HPLC column and Guard column were used. The mobile phase was 65% potassium phosphate (50mmol/l, pH7.0), 35% methanol at a flow rate of 2ml/min. The column was washed nightlywith80%methanol.To5O plofsample/2.5 pmolfl 1,1,3,3-tetraethoxypropane/I-I20 was added 5 p1 of 0.2% (wthrol.) butylated hydroxytoluene and 750 p1 of 1% (vol./vol.) phosphoric acid. Samples were mixed and incubated at room temperature for 10min. Two-hundred and fifty microlitres of 0.6% (wtht) TBA and 445 p1 of H z 0 were added before mixing and incubation in a boiling water bath for 60 min. All samples were cooled and filtered before injection using Millipore Durapore PVDF 0.45 pm pore luer-fitting filters. One-hundred microlitres was injected in each case. 1,1,3,3-Tetraethoxypropane was used as the standard. A standard curve was constructed for each assay and a correlation coefficient of r = 0.997 was obtained. The intra-assay coefficient of variation was 6.7%.
Other measurements
Bilirubin was measured by diazatization reaction, run on an Axon analyser (coefficient of variation ~2 . 3 % ) .
Albumin was determined by the BCG succinate method, run on an Axon analyser (coefficient of variation <3.5%). A method has recently been developed for measuring the antioxidant capacity of body fluids including plasma [25] . The method utilizes the absorbance of a radical cation formed from the interaction of a phenothiazine compound (2,2'-azinobis-3-ethylbenzothiazoline-6-sulphonic acid with myoglobin, which can be recorded spectroscopically at 734nm and measured. The absorbance of this cation is reduced in proportion to the antioxidant capacity of the added fluid. Albumin, urate, ascorbate, a-tocopherol and bilirubin account for 90% of the total plasma antioxidant activity in the TAS assay. Plasma TAS was measured using the Randox TAS kit, and analysed on an RAlOOO analyser (Bayer Instruments). Urate was measured by the uricase method (Sigma Chemical Co.), again on the RAlOOO analyser.
Statistical analysis
All statistical analyses were performed using the Statistical Package for Social Sciences (version 6.1). Analysis of covariance was used to investigate the correlation within subjects. The statistical significance of differences between groups was determined using the Mann-Whitney U-test.
RESULTS
Antioxidant status and lipid peroxidation
A total of 89 samples were collected from 25 infants with a median (range) gestational age of 28 (24-40) weeks and birthweight of 1122 (684-3570) g. 
(14%) 7 (24%)
A weak, insignificant correlation between TAS and MDA was found (r = -0.24, P = 0.056).
Antioxidant status and outcome
Demographic data are shown in Table 1 . All of the infants who died were of a gestation of 25 weeks or under. The TAS did not change significantly over the studied time period.
There was a significant correlation between bilirubin and TAS on days 4 and 10 (r = 0.76, P<O.OOl, n = 22; r = 0.55, P = 0.05, n = 11) ( Table 2) . There was also a significant correlation between urate and TAS on days 0, 4 and 10 (r = 0.49, P = 0.009, n = 27; r = 0.84, P<O.OOl, n = 22; r = 0.77, P = 0.01, n = 12). There was no correlation between plasma albumin and TAS on any day or between the administration of albumin infusions and TAS. There was no correlation between TAS on day 0 and either birthweight or gestation. examined. There was a significant association between lower TAS on day 0 and oxygen dependency at 28 days (P = 0.02). This association was not significant for oxygen dependency at 36 weeks postconceptional age (P=O.28). There was no significant association between TAS on day 0 and death, IVH, retinopathy of prematurity or 'poor outcome' (defined as >stage 3 retinopathy of prematurity, >grade 3 IVH, oxygen dependency at 36 weeks post-conceptional age, or death). There was no association between TAS and grade of IVH or stage of retinopathy.
DISCUSSION
It is widely thought that an imbalance between antioxidant defences and free radical activity may be in part responsible for some of the complications of neonatal intensive care. We set out to discover whether there was any relationship between extracellular antioxidant status and evidence of oxygenderived free radical damage, and subsequently to determine whether depressed antioxidant status related to outcome in preterm infants.
MDA is one of a range of products formed as a consequence of oxygen-derived free-radicalmediated attack on lipids which can be quantitatively measured to give an indication of oxidative stress. There are concerns that it may not accurately reflect the extent of lipid peroxidation since the reaction is non-specific, as it measures aldehydes other than MDA and other lipid degradation products. MDA is reactive and may be further metabolized, and has also been shown to derive from free-radical-mediated attack on some amino acids. Other reaction products also absorb at 532 nm causing colorimetric interference [26]. MDA is only a minor end-product of lipid peroxidation and the acid conditions used cause decomposition of preformed lipid hydroperoxides to MDA, thus exaggerating the levels. However, the available evidence suggests that peroxidation of polyunsaturated fatty acids such as arachidonic acid is the major source of MDA in vivo, and although TBA has been shown to react with a number of compounds to produce pigments which could interfere with the spectrophotometric determination of the TBA-MDA complex [26] , many of these compounds are not normal constituents of biological fluids, or are not formed under the conditions of the TBA assay. In addition, MDA estimation by the TBA assay has been made more specific by the addition of antioxidants such as butylated hydroxytoluene to the mixture, and the use of HPLC increases both the sensitivity and the specificity of the assay, since the TBA-MDA complex is separated from other compounds absorbing at 532 nm.
We found that there was a non-significant, negative correlation between TAS and plasma MDA implying that depressed antioxidant status may allow increased lipid peroxidation, or that free radical damage in the form of lipid peroxidation depleted antioxidant defences, further disrupting the delicate balance between the two and leading to yet more lipid peroxidation. It is likely that this is a vicious circle, with no clear starting or end point. A strong correlation would not be expected, since extracellular antioxidants are only a small part of the antioxidant defence system. We then questioned whether antioxidant status was linked to outcome in preterm infants since, if this were the case, supplementation with antioxidants may help to decrease the incidence of these debilitating disorders.
There are no previously published data of TAS values from infants shortly after birth. Cord blood TAS has been measured [27] -values of 1.46 0.07 mmol/l and 1.21 f 0.08 mmol/l were obtained in term (39-41 weeks, n = 18) and preterm (25-29 weeks, n = 16) infants respectively. TAS was also measured in these infants on day 5, with no significant change found in term infants, while the antioxidant activity in the plasma of premature infants had risen (1.41 f0.09 mmol/l) [27] . TAS measurements in this study are comparable to other published data. TAS was measured during the first 12 h after birth, and values did not differ significantly from those on day 4 or day 10. It is probable that the antioxidant activity of plasma as measured by the TAS assay does rise after birth in preterm infants, possibly in response to the rapidly elevated bilirubin commonly seen in this population. Bilirubin is known to be an important contributor to plasma antioxidant activity as measured by this assay [6] . The TAS assay uses a method of standardization in which bilirubin is a more efficacious antioxidant than urate or albumin (urate has 68% of the antioxidant capacity of bilirubin, and albumin 42%). The relative efficacy of the contribution of each antioxidant does not define the actual importance of the antioxidant because of variations in plasma concentrations. Bilirubin, although usually present in low concentrations in adults ( <20 pmolil), is frequently elevated during the first week of life in premature infants. These high concentrations will inevitably significantly contribute to plasma antioxidant activity as measured by this assay. In a study by Gopinathan et al. [6] , by day 5, bilirubin accounted for 22% of the TAS and urate 26%. In addition, bilirubin may interfere with the assay colorimetrically so that TAS is exaggerated in infants with hyperbilirubinaemia. A correlation (r2 = 0.774) has previously been shown between the TAS and the bilirubin level at day 5 in term infants (day 5 bilirubin 126f92 pmol/l). This association was less significant (r2 = 0.3) in preterm infants who had lower bilirubin levels on day 5 (67 ? 47 ,umol/l). We also found a significant correlation between bilirubin and TAS in premature infants on day 4 ( r = 0.763, P<O.OOl) and day 10 (r=0.55, P=O.O5). These infants had higher bilirubin levels on day 4 and day 10 (Table 2) than those found by Gopinathan et al. [6] . We have also demonstrated a significant correlation between urate and TAS in premature infants (on all days measured). This is not unexpected because of the relatively high concentration of uric acid in plasma (110-730 pmol/l on day 0).
We found no association between plasma antioxidant status in preterm infants and disease except a correlation between day 0 TAS and oxygen dependency at 28 days of life. Those infants that are oxygen dependent at 28days of life, but not at 36 weeks post-conceptional age, are usually very preterm infants who require supplementary oxygen to maintain tissue oxygenation due to their extreme immaturity, but do not have the irreversible pathological changes associated with chronic lung disease. Although we were unable to demonstrate a relationship between day 0 TAS and gestation or birthweight, Gopinathan et al. [6] found a correlation between TAS at birth and birthweight (r2 = 0.434). It is therefore likely that this association is birthweight/gestation linked. Since this association is not a very strong one (P=O.O2), it may be a chance finding, or it may be that samples were collected earlier in the 12 h period on day 0 in those infants who were oxygen dependent at 28 days of life. If this is the case, then stricter time criteria need to be set when studying antioxidant status at birth. TAS was not significantly different in those infants who were still oxygen dependent at 36 weeks post-conceptional age, developed IVH or retinopathy of prematurity and those infants who did not. It is also possible that the number of infants with specific disease pathologies was too small to detect any differences statistically. However, when TAS in babies with poor outcome was compared with infants with good outcome there remained no differences.
If adverse neonatal outcomes are due to deficiencies in antioxidant defences these may be intracellular rather than in the plasma. Alternatively, local extracellular concentrations may be diminished which would not be detected in plasma or urine measurements. It is also possible that despite having similar extracellular antioxidant concentrations, infants with poor outcome are under greater oxidative stress, and the levels observed are insufficient to cope with this shift in oxidant/antioxidant balance. It would be interesting to investigate whether TAS can be augmented by antioxidant supplementation and whether corresponding changes in plasma MDA and outcome were observed.
In conclusion, we have shown that lipid peroxidation may be increased when antioxidant status is lowest, demonstrated by finding a weak negative correlation between extracellular antioxidant status and MDA. Total plasma antioxidant status in preterm infants during the first 12 h was not depressed compared with previously published data in term infants, or later in the first 10 days after birth. Using this assay the total plasma antioxidant activity strongly correlates with plasma bilirubin and urate measurements. Plasma TAS was not related to the incidence of later complications of prematurity.
